138 related articles for article (PubMed ID: 10325535)
1. Functional characterization of bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins expressed by adenovirus recombinants.
Mittal SK; Tikoo SK; van den Hurk JV; Breker-Klassen MM; Yoo D; Babiuk LA
Intervirology; 1998; 41(6):253-60. PubMed ID: 10325535
[TBL] [Abstract][Full Text] [Related]
2. Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses.
Ebata SN; Prevec L; Graham FL; Dimock K
Virus Res; 1992 Jun; 24(1):21-33. PubMed ID: 1320799
[TBL] [Abstract][Full Text] [Related]
3. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.
Schmidt AC; McAuliffe JM; Huang A; Surman SR; Bailly JE; Elkins WR; Collins PL; Murphy BR; Skiadopoulos MH
J Virol; 2000 Oct; 74(19):8922-9. PubMed ID: 10982335
[TBL] [Abstract][Full Text] [Related]
4. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins.
van Drunen Littel-van den Hurk S; Braun RP; Karvonen BC; King T; Yoo D; Babiuk LA
Virology; 1999 Jul; 260(1):35-46. PubMed ID: 10405354
[TBL] [Abstract][Full Text] [Related]
5. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.
Stope MB; Karger A; Schmidt U; Buchholz UJ
J Virol; 2001 Oct; 75(19):9367-77. PubMed ID: 11533200
[TBL] [Abstract][Full Text] [Related]
6. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
[TBL] [Abstract][Full Text] [Related]
7. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
8. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion.
Tsurudome M; Kawano M; Yuasa T; Tabata N; Nishio M; Komada H; Ito Y
Virology; 1995 Oct; 213(1):190-203. PubMed ID: 7483263
[TBL] [Abstract][Full Text] [Related]
9. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
10. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
Heminway BR; Yu Y; Galinski MS
Virus Res; 1994 Jan; 31(1):1-16. PubMed ID: 8165862
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity.
Breker-Klassen MM; Yoo D; Babiuk LA
Can J Vet Res; 1996 Jul; 60(3):228-36. PubMed ID: 8809388
[TBL] [Abstract][Full Text] [Related]
12. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.
Yao Q; Hu X; Compans RW
J Virol; 1997 Jan; 71(1):650-6. PubMed ID: 8985396
[TBL] [Abstract][Full Text] [Related]
13. The bovine parainfluenza virus type-3 (BPIV-3) hemagglutinin/neuraminidase glycoprotein expressed in baculovirus protects calves against experimental BPIV-3 challenge.
Haanes EJ; Guimond P; Wardley R
Vaccine; 1997; 15(6-7):730-8. PubMed ID: 9178475
[TBL] [Abstract][Full Text] [Related]
14. Fusion properties of cells constitutively expressing human parainfluenza virus type 4A haemagglutinin-neuraminidase and fusion glycoproteins.
Nishio M; Tsurudome M; Komada H; Kawano M; Tabata N; Matsumura H; Ikemura N; Watanabe N; Ito Y
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3517-23. PubMed ID: 7996143
[TBL] [Abstract][Full Text] [Related]
15. Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes.
Firouzamandi M; Moeini H; Hosseini D; Bejo MH; Omar AR; Mehrbod P; Ideris A
J Vet Sci; 2016 Mar; 17(1):21-6. PubMed ID: 27051336
[TBL] [Abstract][Full Text] [Related]
16. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
Yao Q; Compans RW
Virology; 1996 Sep; 223(1):103-12. PubMed ID: 8806544
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro characterization of a bivalent DNA containing HN and F genes of velogenic Newcastle disease virus.
Chaturvedi U; Kalim S; Desai G; Ratta B; Kumar R; Ravindra PV; Kumar S; Dash BB; Tiwari S; Sahoo AP; Tiwari AK
Indian J Exp Biol; 2011 Feb; 49(2):140-5. PubMed ID: 21428216
[TBL] [Abstract][Full Text] [Related]
18. An amino acid in the heptad repeat 1 domain is important for the haemagglutinin-neuraminidase-independent fusing activity of simian virus 5 fusion protein.
Ito M; Nishio M; Komada H; Ito Y; Tsurudome M
J Gen Virol; 2000 Mar; 81(Pt 3):719-27. PubMed ID: 10675409
[TBL] [Abstract][Full Text] [Related]
19. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus.
Krüger N; Hoffmann M; Drexler JF; Müller MA; Corman VM; Sauder C; Rubin S; He B; Örvell C; Drosten C; Herrler G
J Virol; 2015 Apr; 89(8):4539-48. PubMed ID: 25741010
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
